Slika na naslovnici

Medicinal plants and natural products for treating overactive bladder

Abstract Background Overactive bladder (OAB) presents a high prevalence of 16-18% worldwide. The pathophysiology of OAB is still poorly understood while effective therapy or countermeasure are very limited. On the other hand, medicinal plants and herbal remedies have been utilized for treating lower...

Shranjeno v:

Bibliografske podrobnosti
Main Authors:	Huanxian Chen (Author), Maggie Pui Man Hoi (Author), Simon Ming Yuen Lee (Author)
Format:	Knjiga
Izdano:	BMC, 2024-03-01T00:00:00Z.
Teme:	article
Online dostop:	Connect to this object online.
Oznake:	Označite Brez oznak, prvi označite!

Podobne knjige/članki

Overactive bladder
od: Anna Zwierzyńska
Izdano: (2021)

The Experimental overactive bladder modelling
od: O. I. Iatsyna, et al.
Izdano: (2018)

The Experimental overactive bladder modelling
od: O. I. Iatsyna, et al.
Izdano: (2018)

OVERACTIVE BLADDER SYNDROME IN CHILDREN
od: E.L. Vishnevskiy
Izdano: (2007)

OVERACTIVE BLADDER SYNDROME IN CHILDREN
od: E.L. Vishnevskiy
Izdano: (2007)

Pharmacokinetics of solifenacin in pediatric populations with overactive bladder or neurogenic detrusor overactivity
od: Stacey Tannenbaum, et al.
Izdano: (2020)

Chapter Biomarkers in the Overactive Bladder Syndrome
od: Silva, Carlos
Izdano: (2012)

Chapter Biomarkers in the Overactive Bladder Syndrome
od: Silva, Carlos
Izdano: (2012)

New in the diagnosis of overactive bladder (review)
od: F N Mahmedzhanova, et al.
Izdano: (2013)

Mirabegron in the Management of Overactive Bladder Syndrome
od: O'Kane M, et al.
Izdano: (2022)

The Association Between Urinary Tract Infection and Overactive Bladder Treatment
od: Kuang-Ming Liao, et al.
Izdano: (2022)

Overactive bladder: An underestimated troublesome problem in women
od: Yiu-Tai Li, et al.
Izdano: (2022)

The application of botulinum toxin in the treatment of overactive bladder
od: Justyna Wojcik, et al.
Izdano: (2020)

The overactive bladder model anatomical and morphological correlates
od: O. I. Iatsyna
Izdano: (2018)

The overactive bladder model anatomical and morphological correlates
od: O. I. Iatsyna
Izdano: (2018)

Fesoterodine for the treatment of urinary incontinence and overactive bladder
od: Pamela Ellsworth
Izdano: (2009)

The Association of Bladder Wall Thickness with Severity of Symptoms in Patients with Overactive Bladder
od: Ronny Adrian, et al.
Izdano: (2017)

A promising protein responsible for overactive bladder in ovariectomized mice
od: Huey-Yi Chen, et al.
Izdano: (2017)

Natural Products as New Approaches for Treating Bladder Cancer: From Traditional Medicine to Novel Drug Discovery
od: Yoo Kang, et al.
Izdano: (2023)

Learning Curve of Botulinum Toxin Bladder Injection for the Treatment of Refractory Overactive Bladder
od: Barba M, et al.
Izdano: (2022)

Overactive bladder (OAB) in women: questionnaire based approach
od: Veena Ganju Malla, et al.
Izdano: (2020)

Clinical and urodynamic effects of tolterodine in women with an overactive bladder
od: Chiu-Lin Wang, et al.
Izdano: (2013)

Literature Review: Quality of Life in Patients with Overactive Bladder
od: Vitaria Wahyu Astuti, et al.
Izdano: (2022)

Clinical Correlation Between Overactive Bladder and Allergy in Children
od: Lu Yin, et al.
Izdano: (2022)

An Evaluation of the Efficacy and Safety of Vibegron in the Treatment of Overactive Bladder
od: Frankel J, et al.
Izdano: (2022)

Profile of mirabegron in the treatment of overactive bladder: place in therapy
od: Sharaf A, et al.
Izdano: (2017)

Pharmacoeconomic feasibility of using Mirabegron in patients with overactive bladder
od: I. N. Dyakov, et al.
Izdano: (2021)

The coexistence of interstitial cystitis and overactive bladder in a patient with lower urinary tract symptoms
od: Ching-Pei Tsai, et al.
Izdano: (2014)

Urinary Incontinence and Overactive Bladder Symptoms in Women with Breast Cancer Being Treated with Oral Hormone Therapy
od: Rebeca Stahlschmidt, et al.

Childhood nocturnal enuresis and clinical course of overactive bladder in women
od: Igor V. Kuzmin, et al.
Izdano: (2024)

Evaluation of quality of life in women with overactive bladder (a survey)
od: F N Makhmejanova
Izdano: (2014)

Relationship between anxiety and overactive bladder syndrome in older women
od: Aline Teixeira Alves, et al.
Izdano: (2014)

Assessing Quality-of-Life of Patients Taking Mirabegron for Overactive Bladder
od: Shaw C, et al.
Izdano: (2023)

Tolterodine Tartrate Proniosomal Gel Transdermal Delivery for Overactive Bladder
od: Rajan Rajabalaya, et al.
Izdano: (2016)

Intracavitary electrical stimulation as treatment for overactive bladder: systematic review
od: Rafaela Fintelman Rodrigues, et al.

Medicinal Plants and Natural Product Research
od: Stankovic, Milan
Izdano: (2020)

The impact of pharmacotherapy on sexual function in female patients being treated for idiopathic overactive bladder: a systematic review
od: Christopher Neal Bruce Evans, et al.
Izdano: (2024)

Astragalus polysaccharides and astragaloside IV ameliorates cyclophosphamide-induced mouse model of overactive bladder
od: Yung-Hsiang Chen, et al.
Izdano: (2020)

The Effectiveness of Anticholinergic Therapy for Overactive Bladders: Systematic Review and Meta-Analysis
od: Andrea Moura Rodrigues Maciel da Fonseca, et al.
Izdano: (2016)

Oxybutynin and tolterodine in a trial for treatment of overactive bladder in Iranian women.
od: Elham Aziminekoo, et al.
Izdano: (2014)